Published in Lung Cancer (Auckl) on March 30, 2016
Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science (2015) 11.89
AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ (2010) 8.73
Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 4.29
Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2010) 3.03
Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection. Ann Thorac Surg (2007) 1.99
Tumor necrosis as a prognostic factor for stage IA non-small cell lung cancer. Ann Thorac Surg (2011) 1.69
The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers. Ann Thorac Surg (2013) 1.60
Clinical outcome of subcentimeter non-small cell lung cancer after surgical resection: single institution experience of 105 patients. J Surg Oncol (2014) 1.43
Predictive clinical outcome of the intratumoral CD66b-positive neutrophil-to-CD8-positive T-cell ratio in patients with resectable nonsmall cell lung cancer. Cancer (2011) 1.25
Motivational readiness for physical activity and quality of life in long-term lung cancer survivors. Lung Cancer (2008) 1.23
Tumor recurrence after complete resection for non-small cell lung cancer. Ann Thorac Surg (2012) 1.18
Epidemiology of lung cancer prognosis: quantity and quality of life. Methods Mol Biol (2009) 1.14
Survival benefits from follow-up of patients with lung cancer: a systematic review and meta-analysis. J Thorac Oncol (2011) 1.12
Risk factors for recurrence and unfavorable prognosis in patients with stage I non-small cell lung cancer and a tumor diameter of 20 mm or less. J Thorac Oncol (2007) 1.07
FDG uptake, glucose transporter type 1, and Ki-67 expressions in non-small-cell lung cancer: correlations and prognostic values. Eur J Radiol (2007) 1.04
Impact and interactions between smoking and traditional prognostic factors in lung cancer progression. Lung Cancer (2009) 1.03
A clinicopathologic prediction model for postoperative recurrence in stage Ia non-small cell lung cancer. J Thorac Cardiovasc Surg (2014) 0.94
Preoperative lymphocyte count is a favorable prognostic factor of disease-free survival in non-small-cell lung cancer. Med Oncol (2012) 0.93
Prognosis of recurrence after complete resection in early-stage non-small cell lung cancer. Korean J Thorac Cardiovasc Surg (2013) 0.92
Risk factors for both recurrence and survival in patients with pathological stage I non-small-cell lung cancer. Eur J Cardiothorac Surg (2013) 0.90
Expression status of ribonucleotide reductase small subunits hRRM2/p53R2 as prognostic biomarkers in stage I and II non-small cell lung cancer. Anticancer Res (2011) 0.90
Differences in patterns of recurrence in early-stage versus locally advanced non-small cell lung cancer. Ann Thorac Surg (2014) 0.89
Expression of fibroblast growth factor 9 is associated with poor prognosis in patients with resected non-small cell lung cancer. Lung Cancer (2013) 0.88
Involvement of FoxM1 in non-small cell lung cancer recurrence. Asian Pac J Cancer Prev (2012) 0.85
Reactive oxygen species modulator 1 (Romo1) overexpression is an independent predictor of poor survival in NSCLC patients who undergo surgical resection. Lung Cancer (2014) 0.85
Ki-67 labeling index is associated with recurrence after segmentectomy under video-assisted thoracoscopic surgery in stage I non-small cell lung cancer. Ann Thorac Cardiovasc Surg (2011) 0.83
Prognostic value of total lesion glycolysis by 18F-FDG PET/CT in surgically resected stage IA non-small cell lung cancer. J Nucl Med (2014) 0.83
Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller. J Surg Res (2013) 0.83
Prognostic significance of histologic differentiation, carcinoembryonic antigen value, and lymphovascular invasion in stage I non-small cell lung cancer. J Thorac Cardiovasc Surg (2014) 0.82
Risk factors of postoperative recurrences in patients with clinical stage I NSCLC. World J Surg Oncol (2014) 0.82
Poor Prognostic Factors in Surgically Resected Stage I Non-small Cell Lung Cancer: Histopathologic and Immunohistochemical Analysis. Korean J Thorac Cardiovasc Surg (2012) 0.79
Overexpression of glucosylceramide synthase and its significance in the clinical outcome of non-small cell lung cancer. Chin Med J (Engl) (2014) 0.79
Expression of Id-1 and VEGF in non-small cell lung cancer. Int J Clin Exp Pathol (2013) 0.78
Consensus: the follow-up of the treated patient. Lung Cancer (2003) 0.78
[Subcellular localization of survivin in non-small cell lung cancer]. Ai Zheng (2009) 0.78
Significance of microscopic invasion into hilar peribronchovascular soft tissue in resection specimens of primary non-small cell lung cancer. Lung Cancer (2010) 0.78
[Pre-operative plasma D-dimer level may predict the poor prognosis within one year after the surgery for non-small cell lung cancer]. Zhongguo Fei Ai Za Zhi (2011) 0.77
Lymphovascular space invasion and tumor differentiation are predictors for postoperative recurrence in patients with pathological stage I nonsmall cell lung cancer. J Chin Med Assoc (2014) 0.76
Simultaneous bilateral primary spontaneous pneumothorax. Respirology (2008) 2.61
Middle mediastinal thymoma. Respirology (2007) 0.95
Standard uptake value of positron emission tomography in clinical stage I lung cancer: clinical application and pathological correlation. Eur J Cardiothorac Surg (2011) 0.79
Postoperative predictors of ipsilateral and contralateral recurrence in patients with primary spontaneous pneumothorax. J Thorac Dis (2016) 0.75
Esophagogastric junction outflow obstruction-related functional chest pain treated using robotic-assisted thoracoscopic esophageal myotomy. J Thorac Dis (2017) 0.75
Adult-onset Langerhans cell histiocytosis of the sternum. J Thorac Dis (2017) 0.75
Mediastinal hemangioma presenting with a characteristic feature on dynamic computed tomography images. J Thorac Dis (2017) 0.75